Skip to main content
SpringerLink
Log in

Follicle-stimulating hormone receptor in gynecological cancers

  • Review Paper
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Expression of follicle-stimulating hormone receptor (FSHR) is normally restricted to the ovary and the testis, where FSH-dependent cell differentiation occurs. FSHR also is involved in the regulation of angiogenesis in ovary. Expression of FSHR has been consistently shown in vascular endothelial cells of human malignant tumors although biological functions of FSHR on tumor neovasculature have not been fully understood. FSHR expression in vasculature of normal or inflammatory tissues is scarce, suggesting its potential role as a diagnostic and therapeutic target in cancer. FSHR has recently been tested as an imaging biomarker for ovarian cancer as FSHR is found to be over-expressed on ovarian tumors. In addition, FSHR is involved in signaling cascades that mediate cancer progression and metastases. Targeting FSHR could provide new agents as imaging and interventional probes not only for ovarian cancer but also many other human solid cancers. In this review, the expression and potential roles of FSHR in human cancers with emphasis on gynecological cancers will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Plant, T. M. & Marshall, G. R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev 22: 764–786 (2001).

    Article  CAS  PubMed  Google Scholar 

  2. Macklon, N. S. & Fauser, B. C. Follicle development during the normal menstrual cycle. Maturitas 30: 181–188 (1998).

    Article  CAS  PubMed  Google Scholar 

  3. Midgley Ar, J. & Jaffe, R. B. Regulation of human gonadotropins: 4. Correlation of serum concentration s of follicle stimulating and luteinizing hormones during the menstrual cycle. J Clin Endocrinol 28: 1699–1703 (1968).

    Article  CAS  PubMed  Google Scholar 

  4. La Marca, A., Carducci Artenisio, A., Stabile, G., Rivasi, F. & Volpe, A. Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium. Gynecol Endocrinol 21: 303–306 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Zheng, W., Magid, M. S., Kramer, E. E. & Chen, Y. T. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 148: 47–53 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Keereweer, S., Van Driel, P. B., Robinson, D. J. & Lowik, C. W. Shifting focus in optical image-guided cancer therapy. Mol Imaging Biol 16: 1–9 (2014).

    Article  PubMed  Google Scholar 

  7. Stilley, J. A. et al. FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice. Biol Reprod 91: 74 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Robinson, L. J. et al. FSH-receptor isoforms and FSHdependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun 394: 12–17 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Radu, A. et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 363: 1621–1630 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Mariani, S. et al. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer. J Urol175:2072–2077; discussion 2077 (2006).

    Article  CAS  PubMed  Google Scholar 

  11. Parrott, J. A., Doraiswamy, V., Kim, G., Mosher, R. & Skinner, M. K. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 172: 213–222 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. Zhang, Z., Jia, L., Feng, Y. & Zheng, W. Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer. Cancer Lett 278: 56–64 (2009).

    Article  CAS  PubMed  Google Scholar 

  13. Feng, Z. et al. A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression. Sci Rep 6: 25408 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lee, C. W., Guo, L., Matei, D. & Stantz, K. Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts. J Biotechnol Biomater 5, doi:10.4172/2155-952X.1000198 (2015).

  15. Yang, C. Q. et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 27: 1502–1506 (2006).

    Article  CAS  PubMed  Google Scholar 

  16. Heubner, M. et al. The haplotype of two FSHR polymorphisms in ovarian cancer—a potential role of ethnology in risk modification. Gynecol Oncol 112: 486–489 (2009).

    Article  CAS  PubMed  Google Scholar 

  17. Noci, I. et al. Human endometrial cancers contain follicle-stimulating hormone receptors: a preliminary study. Gynecol Endocrinol 11: 297–300 (1997).

    Article  CAS  PubMed  Google Scholar 

  18. Misrahi, M. et al. The LH/CG and FSH receptors: different molecular forms and intracellular traffic. Mol Cell Endocrinol 125: 161–167 (1996).

    Article  CAS  PubMed  Google Scholar 

  19. Sairam, M. R., Jiang, L. G., Yarney, T. A. & Khan, H. Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action. Biochem Biophys Res Commun 226: 717–722 (1996).

    Article  CAS  PubMed  Google Scholar 

  20. Simoni, M., Nieschlag, E. & Gromoll, J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 8: 413–421 (2002).

    Article  CAS  PubMed  Google Scholar 

  21. Babu, P. S., Danilovich, N. & Sairam, M. R. Hormoneinduced receptor gene splicing: enhanced expression of the growth factor type I follicle-stimulating hormone receptor motif in the developing mouse ovary as a new paradigm in growth regulation. Endocrinology 142: 381–389 (2001).

    Article  CAS  PubMed  Google Scholar 

  22. Kraaij, R., Verhoef-Post, M., Grootegoed, J. A. & Themmen, A. P. N. Alternative splicing of folliclestimulating hormone receptor pre-mRNA: cloning and characterization of two alternatively spliced mRNA transcripts. J Endocrinol 158: 127–136 (1998).

    Article  CAS  PubMed  Google Scholar 

  23. Wayne, C. M., Fan, H. Y., Cheng, X. D. & Richards, J. S. Follicle-stimulating hormone induces multiple signaling cascades: Evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol 21: 1940–1957 (2007).

    Article  CAS  PubMed  Google Scholar 

  24. Gonzalez-Robayna, I. J., Falender, A. E., Ochsner, S., Firestone, G. L. & Richards, J. S. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): Evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol 14: 1283–1300 (2000).

    Article  CAS  PubMed  Google Scholar 

  25. Hunzicker-Dunn, M. & Maizels, E. T. FSH signaling pathways in immature granulosa cells that regulate target gene expression: Branching out from protein kinase A. Cell Signal 18: 1351–1359 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kuo, S. W., Ke, F. C., Chang, G. D., Lee, M. T. & Hwang, J. J. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFbeta1) in the regulation of ovarian angiogenesis. J Cell Physiol 226: 1608–1619 (2011).

    Article  CAS  PubMed  Google Scholar 

  27. Yarney, T. A. et al. Molecular cloning, structure, and expression of a testicular follitropin receptor with selective alteration in the carboxy terminus that affects signaling function. Mol Reprod Dev 48: 458–470 (1997).

    Article  CAS  PubMed  Google Scholar 

  28. Ulloa-Aguirre, A., Zarinan, T., Pasapera, A. M., Casas-Gonzalez, P. & Dias, J. A. Multiple facets of follicle-stimulating hormone receptor function. Endocrine 32: 251–263 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Themmen, A. P. N. & Huhtaniemi, I. T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21: 551–583 (2000).

    Article  CAS  PubMed  Google Scholar 

  30. Sairam, M. R., Jiang, L. G., Yarney, T. A. & Khan, H. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: Implications for pleiotropic actions of the hormone. Mol Reprod Dev 48: 471–479 (1997).

    Article  CAS  PubMed  Google Scholar 

  31. Touyz, R. M., Jiang, L. & Sairam, M. R. Follicle-stimulating hormone mediated calcium signaling by the alternatively spliced growth factor type I receptor. Biol Reprod 62: 1067–1074 (2000).

    Article  CAS  PubMed  Google Scholar 

  32. Babu, P. S., Krishnamurthy, H., Chedrese, P. J. & Sairam, M. R. Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation. J Biol Chem 275: 27615–27626 (2000).

    CAS  PubMed  Google Scholar 

  33. Li, Y. et al. FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor. Mol Cell Endocrinol 267: 26–37 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lusson, J. et al. cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells. Proc Natl Acad Sci U S A 90: 6691–6695 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Bose, C. K. Follicle Stimulating Hormone Receptor in Ovarian Surface Epithelium and Epithelial Ovarian Cancer. Oncol Res 17: 231–238 (2008).

    Article  PubMed  Google Scholar 

  36. Bose, C. K. Role of nerve growth factor and FSH receptor in epithelial ovarian cancer. Reprod Biomed Online 11: 194–197 (2005).

    Article  CAS  PubMed  Google Scholar 

  37. Heublein, S. et al. Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR). J Ovarian Res 6: 6 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Hong, H. et al. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Mol Pharm 12: 403–410 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Alam, H. et al. Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology 150: 915–928 (2009).

    Article  CAS  PubMed  Google Scholar 

  40. Castro-Fernandez, C., Maya-Nunez, G. & Mendez, J. P. Regulation of follicle-stimulating and luteinizing hormone receptor signaling by. Endocrine 25: 49–54 (2004).

    Article  CAS  PubMed  Google Scholar 

  41. Zeng, H., Zhao, D., Yang, S., Datta, K. & Mukhopadhyay, D. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 278: 20738–20745 (2003).

    Article  CAS  PubMed  Google Scholar 

  42. Arap, W., Pasqualini, R. & Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377–380 (1998).

    Article  CAS  PubMed  Google Scholar 

  43. Gartrell, B. A., Tsao, C. K. & Galsky, M. D. The follicle-stimulating hormone receptor: a novel target in genitourinary malignancies. Urol Oncol 31: 1403–1407 (2013).

    Article  CAS  PubMed  Google Scholar 

  44. Ferlin, A. et al. Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility. Endocr Relat Cancer 15: 429–437 (2008).

    Article  CAS  PubMed  Google Scholar 

  45. Wang, J. et al. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Int J Cancer 103: 328–334 (2003).

    Article  CAS  PubMed  Google Scholar 

  46. Zheng, W. et al. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 76: 80–88 (2000).

    Article  CAS  PubMed  Google Scholar 

  47. Chung, A. S., Lee, J. & Ferrara, N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10: 505–514 (2010).

    Article  CAS  PubMed  Google Scholar 

  48. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144: 646–674 (2011).

    Article  CAS  PubMed  Google Scholar 

  49. Hong, H., Chen, F., Zhang, Y. & Cai, W. New radiotracers for imaging of vascular targets in angiogenesisrelated diseases. Adv Drug Deliv Rev 76: 2–20 (2014).

    Article  CAS  PubMed  Google Scholar 

  50. Xu, Y. et al. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Mol Imaging Biol 16: 578–585 (2014).

    Article  PubMed  Google Scholar 

  51. Siraj, M. A., Pichon, C., Radu, A. & Ghinea, N. Endothelial follicle stimulating hormone receptor in primary kidney cancer correlates with subsequent response to sunitinib. J Cell Mol Med 16: 2010–2016 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Arey, B. J. et al. Identification and characterization of a selective, nonpeptide follicle-stimulating hormone receptor antagonist. Endocrinology 143: 3822–3829 (2002).

    Article  CAS  PubMed  Google Scholar 

  53. Yanofsky, S. D. et al. Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists. J Biol Chem 281: 13226–13233 (2006).

    Article  CAS  PubMed  Google Scholar 

  54. Dias, J. A. et al. A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor. Mol Cell Endocrinol 333: 143–150 (2011).

    Article  CAS  PubMed  Google Scholar 

  55. Arey, B. J. et al. Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochem Biophys Res Commun 368: 723–728 (2008).

    Article  CAS  PubMed  Google Scholar 

  56. Izawa, J. I. & Dinney, C. P. The role of angiogenesis in prostate and other urologic cancers: a review. CMAJ 164: 662–670 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Wang, Z. G., Wu, Z. Q., Liu, Y. & Han, W. D. New development in CAR-T cell therapy. J Hematol Oncol 10, doi:ARTN 53 10.1186/s13045-017-0423-1 (2017).

  58. Roybal, K. T. et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell 167: 419–432 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Simoni, M., Gromoll, J. & Nieschlag, E. The folliclestimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endoc Rev 18: 739–773 (1997).

    CAS  Google Scholar 

  60. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27–31 (1995).

    Article  CAS  PubMed  Google Scholar 

  61. Huang, D. et al. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res 70: 1053–1062 (2010).

    Article  CAS  PubMed  Google Scholar 

  62. Bose, C. K. Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC). J Exp Ther Oncol 6: 201–204 (2007).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea

    Hyun Hoon Chung

  2. Division of Nuclear Medicine and Molecular Imaging, Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Hyun Hoon Chung, Joo Chang Lee & Il Minn

  3. Department of Computer Science, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, USA

    Joo Chang Lee

Authors
  1. Hyun Hoon Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joo Chang Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Il Minn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Il Minn.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chung, H.H., Lee, J.C. & Minn, I. Follicle-stimulating hormone receptor in gynecological cancers. Mol. Cell. Toxicol. 14, 1–7 (2018). https://doi.org/10.1007/s13273-018-0001-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-018-0001-9

Keywords

Search

Navigation